PA200 deficiency caused abnormal transcription of many genes involved in cancers and altered deposition of H3K4me3 or H3K56ac on the genes related to cancer signaling, such as those in the p53, MAPK, and Ras signaling pathways. This evidence concerns the gene TP53 and cancer.